Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Axcan's Photofrin approved and launched in the U.K.

May 3, 2001

Novartis Oncology announces Glivec name change in U.S.

May 3, 2001

Nonestrogenic steroid sulfatase inhibitors identified at Jenapharm

May 2, 2001

Water-soluble prodrug prepared to overcome clinical limitations of quercetin

May 2, 2001

CASB6411 polypeptides and polynucleotides and use in cancer treatment, diagnosis

May 2, 2001

Inex and Elan form joint venture to develop and commercialize Onco TCS

May 2, 2001

Small-molecule dual alphavbeta3/alphavbeta5 integrin inhibitor Sch-221153 inhibits angiogenesis

May 2, 2001

Novogen creates new company to develop phenoxodiol

May 2, 2001

LEraf-AON, a liposomal antisense oligodeoxyribonucleotide for enhancing radiation effects

May 2, 2001

Myriad Genetics' MPC-7869 stabilizes PSA levels in phase II

May 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...